Meet 5, Kövess minket!

Regular abstract title and author information released at 5 p.

EDT Oct. Each regular, Young Investigator Award and late-breaking abstract presenting author meet 5 the opportunity to record a brief presentation to accompany their virtual poster. Posters were viewed beginning November 9th, 8 a.

Author presence were requested during the Virtual Poster Viewing sessions to answers questions and interact with meeting attendees in real time. PDT on Aug. If you had previously submitted a LBA application, you were automatically invited to submit a full LBA during the submission period, Sept. The LBA criteria was altered to accommodate all research regardless of whether the data was ready meet 5 submission during the regular submission period or not.

We hope this additional opportunity for abstract submission provided added assistance for all of the incredible and important work you are doing to continue to move the cancer immunotherapy field forward during this remarkably unusual year. Late-breaking abstracts were considered for, but not limited to, oral abstract presentations during the late-breaking abstract sessions.

Young Investigator Award Abstract Regular abstracts with primary and presenting authors that are students, postdoctoral research fellows, clinical fellows, or meet 5 faculty with three or fewer years on staff and are current SITC members, were eligible to receive a Young Investigator Award.

Young Investigator Award abstracts required a letter of recommendation as well as additional information regarding the percentage of contribution by the primary and presenting author. Those selected for the Presidential Travel Award were invited to give an oral abstract presentation during the virtual Presidential Session.

For more information about the Young Investigator Awards, please click here.